RAVICTI 1.1 g/ml, liquid oral bottle, 25 ml
Active ingredients: Glycerol phenylbutyrate
Commercialized according to BDPMDispensing in France: Prescription only
Liquidbottle, 25 mlgastro-entérale;orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RAVICTI 1,1 g/ml, liquide oral
- Pharmaceutical form
- liquide
- Route of administration
- gastro-entérale;orale
- Presentation description
- 1 flacon en verre de 25 mL avec fermeture de sécurité enfant
- Marketing authorisation holder
- IMMEDICA PHARMA (SUEDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 May 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60150015CIP73009566CIP133400930095669Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PHÉNYLBUTYRATE DE GLYCÉROLliquide | 1,1 g · 1 ml de liquide | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.